Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,697 | -5,670 | -23,654 | -17,334 | -11,186 |
| Depreciation Amortization | 209 | 104 | 51 | 38 | 25 |
| Other Working Capital | -958 | -239 | 1,234 | -400 | 485 |
| Other Operating Activity | 593 | 316 | 1,799 | 1,412 | 1,006 |
| Operating Cash Flow | $-10,853 | $-5,489 | $-20,571 | $-16,284 | $-9,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -59 | -51 | -96 | -86 | -27 |
| Investing Cash Flow | $-59 | $-51 | $-96 | $-86 | $-27 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -184 | -92 | N/A | N/A | N/A |
| Common Stock Issued | 16,992 | 1,884 | 16,981 | 13,816 | 13,812 |
| Financing Cash Flow | $16,808 | $1,792 | $16,981 | $13,816 | $13,812 |
| Beginning Cash Position | 14,104 | 14,104 | 17,791 | 17,791 | 17,791 |
| End Cash Position | 20,000 | 10,356 | 14,105 | 15,237 | 21,905 |
| Net Cash Flow | $5,896 | $-3,748 | $-3,686 | $-2,554 | $4,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,853 | -5,489 | -20,571 | -16,284 | -9,670 |
| Capital Expenditure | -59 | -51 | -96 | -86 | -27 |
| Free Cash Flow | -10,912 | -5,540 | -20,667 | -16,370 | -9,697 |